HON vs PCRX · P/E 36, rev $9.72B vs P/E 174, rev $369.8M
Honeywell International Inc (HON) versus Pacira BioSciences, Inc. (PCRX) — a side-by-side from cached financials, not a winner call.
Honeywell International Inc (HON) is a conglomerates company listed on NASDAQ. It is led by Vimal M. Kapur.
Pacira BioSciences, Inc. (PCRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported HON revenue for 2026-06-30 was $9.72B. Net income was $5.68B. Revenue was up 6.3% from 2026-03-31 to 2026-06-30. HON currently screens at market cap $144.86B and trailing P/E 36.5.
Latest reported PCRX revenue for 2026-06-30 was $369.8M. Net income was $7.6M. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.
HON currently screens at market cap $144.86B and trailing P/E 36.5. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.
Not investment advice. Open the HON and PCRX stock pages for the full models.
Not investment advice.